Production Featured Articles
-
A Biopharma Year In Review — And A Look Ahead To 2020
12/16/2019
The industry has shown surprising resilience and consistency, emerging relatively unscathed from the recession at the beginning of the past decade. Capacity and expansion were relatively unaffected and continue to draw investors seeking healthy returns and a recession-resistant risk profile.
-
Growing With A Flexible, Collaborative CDMO
11/20/2019
Choosing a CDMO that is agile, innovative, and exhibits a willingness to invest in new equipment, infrastructure and services will allow the innovator company and the CDMO to grow together.
-
Pigeons In The Plant: 10 Real-Life Pharma Facility Blunders (And How To Avoid Them)
11/13/2019
There are situations we have come across where we really scratch our heads and say, “What did they just do, and what were they thinking?” This article describes a series of events and activities that we have seen that are at once amusing, baffling, and revealing of the flaws in our industry.
-
What Can We Learn From Compounding Pharmacies Producing Small Parenteral Batches?
11/11/2019
Does the pharmaceutical industry want to sit on the sidelines while its products are being manipulated and modified — a danger? Or will the industry provide its products in a manner or with the tools that will enable compounding pharmacies to succeed in delivering a safe and effective drug to the patient — an opportunity?
-
Can You Trust A Machine For Downstream Bioprocess Buffer Preparation?
11/8/2019
Is automated buffer preparation a solution to the dilemma of balancing increased production capacity against limited footprint expansion alternatives?
-
6 Critical Considerations For Bioprocess Lab Equipment Selection
10/31/2019
As pharma requires more open and flexible systems, special attention should be paid to selection criteria and how bioprocess equipment meets present and future requirements.
-
Viral Vector Development, Manufacturing, And Process Intensification
10/30/2019
An overview of the tools and technologies available for development of viral vectors and to provide insights into techniques that viral vector manufacturers can use to intensify their production processes.
-
Are Good Manufacturing Practices No Longer Good Enough?
10/28/2019
Janet Woodcock’s recent comment on the state of pharmaceutical development,“It’s not working…,” should not surprise anyone. Her continuation, “and, it won’t work in the future," is the more surprising, and particularly troubling statement. What must we change?
-
Can Regulatory And Pharmacopeial Compliance Practices Establish Quality?
10/25/2019
The stated mandate of regulatory authorities (e.g. the FDA) and pharmacopeias (e.g. USP) is to establish and monitor safety, efficacy, and quality of manufactured drug products. This article examines the role of those authorities on quality during production processes.
-
Trends To Watch In China’s Biopharma Industry
10/18/2019
China’s biopharma segment has experienced double-digit growth for the past decade, and the landscape is poised for robust growth for the near future. The country's biopharma sales are on track to reach over $50 billion. Here's why that matters to you.